Drugs / Inflaminat
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01743404 | Sep 2007 → Feb 2013 | atherosclerosis | Institute for Atherosclerosis Research, Russia | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inflaminat | “Inflaminat 500 mg tablet by mouth three times a day” NCT01743404 ↗ |
| Route | Oral | “Inflaminat 500 mg tablet by mouth three times a day” NCT01743404 ↗ |